In conclusion, we identified four novel CYP4V2 mutations in 10/19 BCD patients as well as the first genomic rearrangement (large deletion) implicating CYP4V2. Our results emphasize the importance of CNV screening in BCD. This evidence concerns the gene CYP4V2 and Bietti crystalline dystrophy.